Topic Menu
► Topic MenuTopic Editors


Immunotherapy and Targeted Therapy in Breast Cancer
Topic Information
Dear Colleagues,
Breast cancer remains a major cause of cancer mortality worldwide. The hope for improved survival of breast cancer patients comes from the many immunotherapeutic and targeted therapeutic strategies currently being studied. These strategies include the approved clinical use of immunotherapeutic checkpoint inhibitors for metastatic triple-negative breast cancer positive for PD-L1 expression and poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of BRCA-deficient breast cancers. Although promising, the responses to these targeted strategies are limited and additional advances in patient stratification and novel drug/target combinations are needed. We invite breast cancer studies that investigate the various aspects of immunotherapeutic and targeted therapeutic strategies. In this Topic, original research articles and reviews are welcome. Breast cancer research areas may include (but are not limited to) pre-clinical and clinical studies that investigate the various aspects of immunotherapeutic and targeted therapeutic strategies, as well novel methods of drug delivery.
Dr. Paola Marcato
Dr. Suresh Gadde
Topic Editors
Keywords
- breast cancer
- immunotherapy
- immune checkpoint blockade
- targets
- inhibitors
- precision medicine
- cancer nanomedicine
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
---|---|---|---|---|---|
![]()
Biology
|
3.6 | 5.7 | 2012 | 16.4 Days | CHF 2700 |
![]()
Cancers
|
4.5 | 8.0 | 2009 | 17.4 Days | CHF 2900 |
![]()
Current Oncology
|
2.8 | 3.3 | 1994 | 19.8 Days | CHF 2200 |
![]()
Diseases
|
2.9 | 0.8 | 2013 | 21.4 Days | CHF 1800 |
![]()
Onco
|
- | - | 2021 | 27.8 Days | CHF 1000 |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.